BlackRock Institutional Trust’s Imunon IMNN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$299K Hold
359
﹤0.01% 3539
2016
Q3
$1.2M Hold
359
﹤0.01% 3229
2016
Q2
$1.25M Hold
359
﹤0.01% 3233
2016
Q1
$1.43M Hold
359
﹤0.01% 3172
2015
Q4
$1.89M Hold
359
﹤0.01% 3147
2015
Q3
$1.64M Hold
359
﹤0.01% 3182
2015
Q2
$2.31M Buy
359
+20
+6% +$142K ﹤0.01% 3060
2015
Q1
$2.48M Buy
339
+10
+3% +$69.6K ﹤0.01% 3014
2014
Q4
$2.1M Hold
329
﹤0.01% 3075
2014
Q3
$2.67M Hold
329
﹤0.01% 2945
2014
Q2
$3.13M Buy
329
+14
+4% +$125K ﹤0.01% 2992
2014
Q1
$2.91M Buy
315
+74
+31% +$770K ﹤0.01% 3008
2013
Q4
$2.57M Buy
241
+85
+54% +$1.02M ﹤0.01% 3062
2013
Q3
$2.22M Buy
156
+8
+5% +$118K ﹤0.01% 3075
2013
Q2
$1.86M Buy
+148
New +$2.06M ﹤0.01% 3114

Other funds holding IMNN

BlackRock Institutional Trust's IMNN Position: Q4 2016 in Review

BlackRock Institutional Trust held its Imunon (IMNN) position steady in Q4 2016 at 359 shares worth $299K. The position accounts for ﹤0.01% of the portfolio, ranked #3539.

BlackRock Institutional Trust first reported a position in IMNN in Q2 2013 and has held it in 15 quarters since. The position peaked at $3.13M in Q2 2014. 23 funds tracked by Wall St. Rank hold IMNN as of Q4 2016.

  • BlackRock Institutional Trust held 359 shares of Imunon worth $299K as of Q4 2016.
  • BlackRock Institutional Trust left its Imunon share count unchanged in Q4 2016.
  • Imunon made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3539 holding.
  • BlackRock Institutional Trust first reported a position in Imunon in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Imunon position peaked at $3.13M in Q2 2014.
  • 23 funds tracked by Wall St. Rank held Imunon as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.